Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico

Revista de Saude Publica

Volumn 41, Issue 4, 2007, Pages 523-529

  Arredondo, Armando ^a,b   Carrillo, Carlos ^b   Zuñiga, Alexis ^b  

^a Health Services Unit   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Health care costs; Health expenditures; Mexico; Models, statistical; Smoking, epidemiology; Smoking, trends; Time series studies

Indexed keywords

EID: 34548166761     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102006005000033     Document Type: Article

References (19)

1. Arredondo A, Zuñiga A. Epidemiological and economic burden of hypertension in Latin America: evidence from Mexico. Am J Hypertens. 2006;19(6):140-7.
2. Arredondo A. Gerencia y economía de servicios de salud. México: Centro Interamericano de Estúdios em Seguridad Social; 2005. Conceptos básicos para el análisis del mercado de servicios de salud; p. 163-74.
3. Bartecchi CE, Mackenzie TD, Schrier RW. The global tobacco epidemic. Sci Am.. 2005; 272(5):44-51.
4. Bartecchi CE, Mackenzie TD, Schrier RW. The human costs of tobacco use (2). N Engl J Med. 1994;330(13):975-80.
5. Benatar SR. Respiratory health in a globalizing world. Am J Respir Crit Care Med. 2001;163(5):1064-7.
6. The catastrophic failures of public health. Lancet. 2004;363(9411):745.
7. Practice expense costs in pulmonary and critical care practices. Is providing patient care still economically feasible? Am J Respir Crit Care Med. 2001;163(7):1524-7.
8. Miller VP, Ernst C, Collin F. Smoking-attributable medical care costs in the USA. Soc Sci Med. 1999;48(3):375-91.
9. Murray A. Statistical modelling in GLIM. New York: Oxford University Press; 2003. Statistical modelling and statistical inference: measurement error in the explanatoriy variables: Box-Jenkins technique, p. 67-112.
10. Jamison D, Mosley H, Measham A, Bobadilla JL, editors. Disease control priorities in developing countries. Washington: Oxford University Press, 1994. Cost-effectiveness of treatment: lung cancer; Chap 21, p. 540-5.
11. Noronha MF, Veras CT, Leite IC, Martins MS, Braga Neto F, Silver L. The development of diagnosis-related groups-DRGs. Methodology for classifying hospital patients. Rev Saude Publica: 1991;25(3):198-208.
12. Public Health Service. Report of the Advisory Committee to the Surgeon General of the Public Health Sevice. Smoking and health. Washington: U. S. Department of Health, Education, and Welfare, 1964. p. 387. (PHS Publication, 1103).
13. Rice D, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q. 1986;64(4):489-547.
14. Sansores R. Evaluación del programa para dejar de fumar del INER. Rev Inst Nac Enf Resp. 1998;11(1):29-35.
15. Samet JM. Los riesgos del tabaquismo activo y pasivo. Salud Pública Méx. 2002;44 Suppl 1:S144-60.
16. Warner KE. The economics of tobacco: myths and realities. Tob Control. 2000;9(1):78-89.
17. World Bank. World Development report 1993: investing in health. Washington; 1993.
18. World Health Organization'. The world health report 1999: making a difference. Geneva; 1999. Combating the tobacco epidemia; p. 65-79.
19. Panamerican Health Organization. Health situation in the Americas: basic indicators 2004. Washington, DC; 2005: p. 234-56.